Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06420271 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Cerebellar tACS-iTBS in Ataxia

Study acronym: EtABeta
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 17, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv6
  2. Primary endpoints: 2 to 1
    • Secondary endpoints revised (4)
    v5
  3. Secondary endpoints revised (4)
    • Study description expanded, about 273 words
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Primary endpoints revised (2)
    • Study sites: 0 to 1
    v3
  5. Start date: Jul 1, 2024 to May 1, 2025v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ataxia refers to a group of neurological disorders characterized by impaired coordination and balance due to dysfunction in the cerebellum or its connections. Traditional therapeutic approaches for ataxia have shown limited efficacy, prompting researchers to explore alternative interventions. Non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), and intermittent theta burst stimulation (iTBS), have emerged as potential therapeutic options. The aim of this study is to investigate the combined effect of tACS-iTBS on balance functions in ataxia disorders.
Trial Details
NCT Number NCT06420271
Lead Sponsor I.R.C.C.S. Fondazione Santa Lucia
Conditions
(from sponsor)		 Ataxia
Related terms Ataxia
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov